Channels

 

Special Offers & Promotions

 

 

Latest News

 

 

View Channel

New Products

 

 

View Channel

Video Presentations

 

 

View Channel

Separation Science

 

 

View Channel

Microscopy & Image Analysis

 

 

View Channel

Laboratory Automation & IT Solutions

 

 

View Channel

 

Synexus expands its field of vision with ophthalmology trials

publication date: Feb 10, 2011
 | 
author/source: Synexus

Synexus.Synexus, the world's largest company responsible for the recruitment and running of clinical trials, has won its first contract to conduct ophthalmology studies. The Manchester-based company announced its intention to become involved in ophthalmology trials last October, following discussions with leading sponsors

The trial, conducted on behalf of a leading pharmaceutical company, will be carried out across several of Synexus' 26 Dedicated Research Centres, with recruitment already underway.

Chief Executive of Synexus, Dr Christophe Berthoux, is delighted with these significant new business wins: "We have worked hard to secure the right expertise to support our developments in the ophthalmology field and also to invest in the best technology to support the trials sponsors are looking to undertake. It is further testimony to our reputation, gained in other therapeutic areas, particularly in terms of rapid recruitment, that these sponsors have come to us to deliver their studies for ocular drug development.

Synexus has recently announced its intention to establish a presence in the US. The company is now enjoying the support of more leading sponsors including pharmaceutical organisations and major CROs for its model that recruits high numbers of patients to a limited number of sites.

About Synexus

Synexus® headquartered in Manchester, England, is the world's largest multi-national company dedicated to the recruitment and running of clinical trials at its own research centres across the globe on behalf of its pharmaceutical, biotech and CRO clients.  Synexus now has 26 Dedicated Research Centres across the UK, Germany, Austria, Poland, Hungary, Ukraine, Bulgaria, India and South Africa staffed by full-time GCP-trained investigators.

The traditional way of recruiting for clinical trials through individual doctors is still by far the most common method, despite the fact that each doctor only recruits an average of five patients per study and more than 60 percent recruit one or less.  This incredibly costly model remains the norm.



 

News Channels

 

 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month

Top 10 most popular articles this month

 

 

Today's Picks

 

 

 

 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners

 

Exhibitions & Events